Memorial Sloan Kettering doctors are among the most experienced in the world at diagnosing and treating primary liver cancer. Over the past decade, we have treated more than 5,000 people with liver cancer. Our group of nearly 30 specialists includes surgeons, medical oncologists, and interventional radiologists.
We work as a team to cure your condition and give you the best care possible. We will give you a customized care plan that fits your unique needs.
MSK is one of the few cancer centers in the nation with extensive experience in treating very rare types of liver cancer called fibrolamellar-hepatocellular carcinoma and cholangiocarcinoma.
Learn more about our liver cancer experts in the list below.
Member, David M. Rubenstein Center for Pancreatic Cancer Research
Enid A. Haupt Chair in Surgery; Director, Hepatopancreatobiliary Fellowship Program; Director, Surgical Oncology Fellowship Program
Chair, Department of Surgery; Murray F. Brennan Chair in Surgery
Chief, Hepatopancreatobiliary Service; Leslie Blumgart Chair in Surgery
Director of Global Cancer Disparity Initiatives
Co-Director, Surgical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research
Associate Director for Clinical Research, David M. Rubenstein Center for Pancreatic Cancer Research; Winthrop Rockefeller Chair of Medical Oncology
Regional Director, Early Drug Development
Edward S. Gordon Chair in Medical Oncology
Chief for External Beam Radiotherapy, Long Island
Vice Chair, Department of Radiation Oncology
Co-Chief, Multi-Disciplinary Spine Tumor Service
Vice Chair of Information Technology, Safety, Quality, and Performance Improvement, Department of Radiology
Director, Interventional Radiology, MSK Westchester
Associate Director, Interventional Radiology Training Program
Director, Interventional Radiology Training Program
Director, Interventional Radiology, MSK Monmouth
Director, Interventional Radiology, MSK Commack
Chief, Interventional Radiology Service
